NI

Nextech Invest Portfolio holdings

AUM $528M
This Quarter Return
+5.45%
1 Year Return
-0.88%
3 Year Return
+164%
5 Year Return
–
10 Year Return
–
AUM
$310M
AUM Growth
+$310M
Cap. Flow
+$791K
Cap. Flow %
0.26%
Top 10 Hldgs %
92.96%
Holding
14
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

1
RVMD icon
Revolution Medicines
RVMD
$4.93M

Top Sells

1
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
$4.14M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$7.1B
$82.6M 26.68% 4,189,529 +250,000 +6% +$4.93M
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
$64.9M 20.95% 13,104,424 – –
KNTE
3
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$31.8M 10.27% 2,661,888 -346,355 -12% -$4.14M
TYRA icon
4
Tyra Biosciences
TYRA
$675M
$22.1M 7.15% 2,518,582 – –
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$18.4M 5.95% 263,914 – –
PMVP icon
6
PMV Pharmaceuticals
PMVP
$74.2M
$16.5M 5.33% 1,385,807 – –
CGEM icon
7
Cullinan Oncology
CGEM
$445M
$15.7M 5.06% 1,221,145 – –
ARVN icon
8
Arvinas
ARVN
$568M
$12.8M 4.13% 287,251 – –
BPMC
9
DELISTED
Blueprint Medicines
BPMC
$12.4M 4.01% 188,228 – –
RLAY icon
10
Relay Therapeutics
RLAY
$619M
$10.6M 3.44% 475,485 – –
SPRY icon
11
ARS Pharmaceuticals
SPRY
$1.15B
$10.1M 3.26% 1,910,029 – –
KRON
12
DELISTED
Kronos Bio
KRON
$4.86M 1.57% 1,451,537 – –
THRX
13
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$3.55M 1.15% 611,310 – –
CCCC icon
14
C4 Therapeutics
CCCC
$185M
$3.3M 1.06% 375,857 – –